Vyome Holdings HIND
NASDAQ HIND
$2.06 -0.03 (-1.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vyome Holdings (HIND) Other Operating Expenses (2020 - 2026)

Vyome Holdings (HIND) posted Other Operating Expenses of $2610.0 for Q2 2026, little changed on a QoQ basis from $2605.0 in Q1 2026, and up 100.37% year-over-year from $1302.6 in Q2 2025.

Analysis

Vyome Holdings (HIND) Other Operating Expenses (2020 - 2026) Analysis & Trends

Vyome Holdings has reported Other Operating Expenses for 7 years, with the latest figure at $2610.0 in Q2 2026.

  • On a quarterly basis, Other Operating Expenses rose 100.37% year-over-year to $2610.0 in Q2 2026; TTM through Jun 2026 was $7.7 million, a 803.9% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 866.65% from the prior year.
  • Other Operating Expenses was $2610.0 for Q2 2026 at Vyome Holdings, roughly flat from $2605.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $7.7 million in Q3 2025, with the low at -$708032.0 in Q2 2025.
  • Average Other Operating Expenses over 5 years is $817626.5, with a median of $3276.0 recorded in 2024.
  • The largest YoY upside for Other Operating Expenses was 174021.05% in 2025 against a maximum downside of 277.45% in 2025.
  • Over 5 years, Other Operating Expenses stood at -$146000.0 in 2022, then soared by 122.6% to $33000.0 in 2023, then plunged by 88.29% to $3864.0 in 2024, then tumbled by 30.43% to $2688.0 in 2025, then dropped by 2.9% to $2610.0 in 2026.
  • The last three Other Operating Expenses figures came in at $2610.0 (Q2 2026), $2605.0 (Q1 2026), and $2688.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Vyome Holdings 14.46 Mn 6.57 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,610.00
Mar 31, 2026 2,605.00
Dec 31, 2025 2,688.00
Sep 30, 2025 7.71 Mn
Jun 30, 2025 -708,032.00
Mar 31, 2025 -396,477.00
Dec 31, 2024 3,864.00
Sep 30, 2024 4,427.00
Jun 30, 2024 399,000.00
Mar 31, 2024 484,000.00
Jun 30, 2023 33,000.00
Mar 31, 2023 2.18 Mn
Dec 31, 2022 -146,000.00
Sep 30, 2022 -1,000.00
Jun 30, 2022 -381,000.00
Mar 31, 2022 3.89 Mn
Dec 31, 2021 33.61 Mn
Sep 30, 2021 3.25 Mn
Jun 30, 2021 1.44 Mn
Mar 31, 2021 1.25 Mn